Rediscovering Hydroxychloroquine as a Novel Insulin Sensitizer
NCT02124681
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Insulin Resistance
Interventions
DRUG:
Hydroxychloroquine
OTHER:
Placebo
Sponsor
University of Pittsburgh